1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Saluda Medical, Inc.

Saluda Medical, Inc.

SLD.AX
Saluda Medical, Inc.AU flagAustralian Securities Exchange
0.41
AUD
- -
- -
105.91MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Company Profile APIChatGPT
Sector
Healthcare
Industry
Medical - Devices
Address
9401 James Avenue S Bloomington MN United States of America 55431
IPO Date
Dec 4, 2025
CIK
0001973574
Website
saludamedical.com
Similar Companies
Telesis Bio, Inc. (TBIO)
MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
Ambu A/S (AMBU-B.CO)
Itamar Medical Ltd. (ITMR)
Novacyt S.A. (ALNOV.PA)
LifeTech Scientific Corporation (LFTSF)
Business
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.